Literature DB >> 9738990

Cytomegalovirus infection.

H L Brown1, M P Abernathy.   

Abstract

Cytomegalovirus (CMV) infection is the most common perinatal infection and may result in severe injury to the fetus. Forty percent to 50% of infants delivered to mothers with primary CMV will have congenital infections. Of these, 5% to 18% will be overtly symptomatic at birth. The mortality rate in these children is almost 30%; approximately 80% of the survivors have severe neurological morbidity. The majority of congenitally infected infants will be asymptomatic at birth; 10% to 15% of these children subsequently have sequelae such as visual and auditory defects. If recurrent or reactivated CMV infection develops during pregnancy, the risk of serious fetal injury is very low. Similarly, neonatal infection acquired during delivery or from breast feeding also poses minimal risk to the child. Because antimicrobial therapy and immunoprophylaxis for CMV infection are unsatisfactory, pregnant women must be educated about preventive measures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738990     DOI: 10.1016/s0146-0005(98)80014-1

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  12 in total

1.  Neurotropic viruses and cerebral palsy: population based case-control study.

Authors:  Catherine S Gibson; Alastair H MacLennan; Paul N Goldwater; Eric A Haan; Kevin Priest; Gustaaf A Dekker
Journal:  BMJ       Date:  2006-01-06

2.  Congenital cytomegalovirus infection. Is there a breakthrough?

Authors:  B Bar-Oz; M Berkovitch; L Ford-Jones; G Koren
Journal:  Can Fam Physician       Date:  2001-06       Impact factor: 3.275

3.  Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection.

Authors:  Y Schlesinger; D Halle; A I Eidelman; D Reich; D Dayan; B Rudensky; D Raveh; D Branski; M Kaplan; V Shefer; D Miron
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-09       Impact factor: 5.747

Review 4.  [Cholestasis-associated hepatopathies in neonates and infants].

Authors:  G Knöpfle; A Adam; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

Review 5.  Congenital cytomegalovirus infection.

Authors:  Alexander K C Leung; Reginald S Sauve; H Dele Davies
Journal:  J Natl Med Assoc       Date:  2003-03       Impact factor: 1.798

6.  Washing our hands of the congenital cytomegalovirus disease epidemic.

Authors:  Michael J Cannon; Katherine Finn Davis
Journal:  BMC Public Health       Date:  2005-06-20       Impact factor: 3.295

7.  Maternal and Congenital cytomegalovirus infection and zero rubella IgM prevalence in newborns in St.Paul's Hospital Millennium Medical College.

Authors:  Yeshwondm Mamuye; Balkachew Nigatu; Delayehu Bekele; Mekonen Getahun
Journal:  BMC Res Notes       Date:  2016-10-21

8.  Characteristics and prognosis of hepatic cytomegalovirus infection in children: 10 years of experience at a university hospital in Korea.

Authors:  Chae-Yeon Min; Joo Young Song; Su Jin Jeong
Journal:  Korean J Pediatr       Date:  2017-08-14

Review 9.  Emerging/re-emerging viral diseases & new viruses on the Indian horizon.

Authors:  Devendra T Mourya; Pragya D Yadav; P T Ullas; Sumit D Bhardwaj; Rima R Sahay; Mandeep S Chadha; Anita M Shete; Santosh Jadhav; Nivedita Gupta; Raman R Gangakhedkar; Pradeep Khasnobis; Sujeet K Singh
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

10.  Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.

Authors:  Fernando A B Colugnati; Stephanie A S Staras; Sheila C Dollard; Michael J Cannon
Journal:  BMC Infect Dis       Date:  2007-07-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.